M.A. Bray
- Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects 20
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology 3
- Immunology and Allergy top 1%
- Immunology top 2%
- Immune Response and Inflammation 6
- Macrophage Migration Inhibitory Factor 5
- Physiology top 2%
- Asthma and respiratory diseases 10
-
- Estrogen and related hormone effects 7
-
- Antiplatelet Therapy and Cardiovascular Diseases 5
-
- Cytokine Signaling Pathways and Interactions 5
- Co-authors
- A. W. Ford‐HutchinsonM. J. H. SmithMichael ShipleyMira DoigDuncan A. GordonJohn E. MorleyF.M. CunninghamR. W. Jones
- Journals
- Inflammation Research (5 papers)Prostaglandins (4 papers)British Journal of Pharmacology (4 papers)
- Partner nations
- United KingdomSwitzerlandUnited States
In The Last Decade
M.A. Bray
39 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Pharmacology 1.2k
- Biochemistry 498
- Immunology and Allergy 410
- Immunology 1.3k
- Physiology 1.1k
Countries citing papers authored by M.A. Bray
This map shows the geographic impact of M.A. Bray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Bray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Bray more than expected).
Fields of papers citing papers by M.A. Bray
This network shows the impact of papers produced by M.A. Bray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Bray. The network helps show where M.A. Bray may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M.A. Bray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 19 | |
| 2 | Strategies in the design of peptidoleukotriene antagonists. | 1993 | 5 |
| 3 | 1989 | 30 | |
| 4 | Leukotriene D4 (LTD4) antagonists: structure activity relationships of stable phenylsubstituted leukotriene analogs. | 1989 | 1 |
| 5 | 1986 | 91 | |
| 6 | 1984 | 40 | |
| 7 | 1981 | 5 | |
| 8 | 1981 | 4 | |
| 9 | 1981 | 194 | |
| 10 | 1981 | 12 | |
| 11 | 1981 | 68 | |
| 12 | 1980 | 13 | |
| 13 | 1980 | 17 | |
| 14 | 1980 | 31 | |
| 15 | 1980 | 1 | |
| 16 | 1978 | 8 | |
| 17 | 1976 | 8 | |
| 18 | 1976 | 334 | |
| 19 | Role of prostaglandins in reactions of cellular immunity. | 1974 | 46 |
| 20 | Proceedings: Role of prostaglandins in reactions of cellular immunity. | 1974 | 18 |
About M.A. Bray
M.A. Bray is a scholar working on Pharmacology, Immunology, Immunology and Allergy, Physiology and Biochemistry, having authored 42 papers that have together received 3.8k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (20 papers), Asthma and respiratory diseases (10 papers), Estrogen and related hormone effects (7 papers), Immune Response and Inflammation (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Macrophage Migration Inhibitory Factor (5 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). The work is most often cited by research in Pharmacology (1.2k citations), Biochemistry (498 citations), Immunology and Allergy (410 citations), Immunology (1.3k citations) and Physiology (1.1k citations). M.A. Bray has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include A. W. Ford‐Hutchinson, M. J. H. Smith, Michael Shipley, Mira Doig, Duncan A. Gordon, John E. Morley, F.M. Cunningham, R. W. Jones, D.H. Nugteren and D. A. van Dorp. Their work appears in journals such as Inflammation Research, Prostaglandins, British Journal of Pharmacology, Journal of Pharmacy and Pharmacology and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.